Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients

Background: Cirrhosis is a common chronic liver disease characterized by irreversible diffuse liver damage. Intestinal microbiome dysbiosis and metabolite dysfunction contribute to the development of cirrhosis. Lactitol (4-β-D-galactopyranosyl-D-glucitol) was previously reported to promote the growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haifeng, Chen, Liang, Pan, Xiaxia, Yao, Yujun, Zhang, Hua, Zhu, Xiaofei, Lou, Xiaobin, Zhu, Chunxia, Wang, Jun, Li, Lanjuan, Wu, Zhongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551616/
https://www.ncbi.nlm.nih.gov/pubmed/34722597
http://dx.doi.org/10.3389/fmed.2021.762930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551616/
https://www.ncbi.nlm.nih.gov/pubmed/34722597
http://dx.doi.org/10.3389/fmed.2021.762930

Ejemplares similares